Cita APA

PERNAS SIMON, S., Pascual, T., Villacampa Javierre, G., Oliveira, M., Escriva de Romani, S., Paré, L., & Nuciforo, P. (2025). Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: Final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial.

Citación estilo Chicago

PERNAS SIMON, SONIA, Tomás Pascual, Guillermo Villacampa Javierre, Mafalda Oliveira, Santiago Escriva de Romani, Laia Paré, y Paolo Nuciforo. Palbociclib and Trastuzumab for HER2-positive Metastatic Breast Cancer: Final Overall Survival Results of Cohort A and B of SOLTI-1303-PATRICIA Trial. 2025.

Cita MLA

PERNAS SIMON, SONIA, et al. Palbociclib and Trastuzumab for HER2-positive Metastatic Breast Cancer: Final Overall Survival Results of Cohort A and B of SOLTI-1303-PATRICIA Trial. 2025.